Vaccination for Human Papillomavirus: an historic and bibliometric study

Hum Vaccin Immunother. 2021 Apr 3;17(4):934-942. doi: 10.1080/21645515.2020.1805991. Epub 2020 Sep 21.

Abstract

A systematic literature review was conducted to describe in a historical perspective the evolution of studies concerning HPV vaccination. The search identified 794 articles of which 568 were included. The first article was published in 2001, and the maximum annual number of publications was reached in 2014. The average number of authors per paper was 8.8. Papers originated from 49 different countries, with the USA accounted for the maximum number of publications (n = 217). Efficacy (46.5%) and safety (31.0%) were the most prevalent objectives. Clinical trials constituted the largest group of methods (37.9%). Chronological trends did not reveal any lasting curve-crossings, indicating that the priority topics have remained the same. The geographical origin of these studies raises questions about the transposability of the results to populations where HPV vaccination has been studied only a little. This study could help guide future research to less-studied research objectives, particularly for vaccines.

Keywords: Journal Impact Factor; Papillomavirus vaccines; bibliometrics; systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Alphapapillomavirus*
  • Bibliometrics
  • Humans
  • Papillomaviridae*
  • Vaccination

Grants and funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.